CD44-targeted chimeric antigen receptor-T eradicates acute myeloid leukaemic stem cells

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Article numbere156
JournalClinical and Translational Discovery
Volume2
Issue number4
DOIs
StatePublished - Dec 2022

Keywords

  • Acute myeloid leukaemia
  • CAR-T cells
  • CD44
  • cytotoxicity
  • hematopoietic cells
  • tumor relapse

ASJC Scopus subject areas

  • Cell Biology
  • Genetics
  • Clinical Biochemistry
  • Molecular Medicine
  • General Medicine

Cite this